We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

News   Apr 16, 2019 | Original story from Harvard University

 
Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

Cancerous cells (dark purple) start to spread in a patient's bone marrow. Mutated genes often spark rampant AML cancer growth. Credit: The Armed Forces Institute of Pathology (AFIP)

 
 
 

RELATED ARTICLES

CRISPR Cuts Open New Avenues in CAR T-cell Therapy

News

According to a study published in the Blood journal, drug profiling and the CRISPR-Cas9 gene editing method have opened new avenues in the development of CAR T-cell therapy, used to treat leukaemia and lymphoma.

READ MORE

Long-hidden Metabolic System Unlocks Cancer Secrets

News

Researchers have identified a long-hidden metabolic system in cells, which could provide a new opportunity to find ways to suppress cell proliferation in cancer.

READ MORE

Potential Therapeutic Target for Alzheimer's

News

A previously unknown gene and associated protein which could potentially be suppressed to slow the advance of Alzheimer’s have been discovered, presenting a potential therapeutic target to combat the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE